<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Junyu Xu</submitter><species>Mycolicibacterium Smegmatis Mc2 51</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0015202000</full_dataset_link><submitter_email>jyxu@simm.ac.cn</submitter_email><submitter_affiliation>Chinese Academy of Sciences Shanghai Institute of Materia Medica</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol></additional><is_claimable>false</is_claimable><name>Lysine Acetylation of Translation Initiation Factor IF-2 Mediated by Mycobacterial Acetyltransferase Eis</name><description>In our study, we employed the non-pathogenic Mycobacterium smegmatis as a model organism and applied a multi-omics approach to elucidate the substrate specificity and regulatory function of the mycobacterial acetyltransferase Eis. Through the integration of TMT-based acetyl-proteomics, dimethyl labeling-based acetyl-proteomics, and protein interactome analyses, we identified lysine 509 of the translation initiation factor IF-2 (infB), which is involved in ribosomal function, as a novel substrate of Eis. Acetylation at K509 was found to inhibit the GTPase activity of infB, leading to a decrease in the biosynthesis of nascent proteins. Furthermore, we demonstrated that Eis-mediated acetylation of infB reduced the tolerance of bioengineered M. smegmatis strain to the ribosome-targeting antibiotic clarithromycin and increased the production of inflammatory cytokines infected in the macrophage THP-1 cell line and mouse kidney. Our findings elucidate the Eis-infB regulatory axis, highlighting the critical roles of infB K509 acetylation in modulating mycobacterial homeostasis, ribosomal function, and host immune responses.</description><dates><publication>Fri Apr 10 00:00:00 BST 2026</publication></dates><accession>PXD076847</accession><cross_references><TAXONOMY>1445611</TAXONOMY></cross_references></HashMap>